KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Invested Capital (2016 - 2025)

Historic Invested Capital for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $2.0 billion.

  • Idexx Laboratories' Invested Capital rose 792.97% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 792.97%. This contributed to the annual value of $2.2 billion for FY2024, which is 139.27% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' Invested Capital is $2.0 billion, which was up 792.97% from $2.0 billion recorded in Q2 2025.
  • Idexx Laboratories' Invested Capital's 5-year high stood at $2.2 billion during Q4 2024, with a 5-year trough of $828.4 million in Q1 2021.
  • Over the past 5 years, Idexx Laboratories' median Invested Capital value was $1.5 billion (recorded in 2021), while the average stood at $1.5 billion.
  • As far as peak fluctuations go, Idexx Laboratories' Invested Capital surged by 12106.68% in 2021, and later crashed by 1052.71% in 2022.
  • Quarter analysis of 5 years shows Idexx Laboratories' Invested Capital stood at $1.5 billion in 2021, then dropped by 10.53% to $1.4 billion in 2022, then surged by 58.34% to $2.2 billion in 2023, then grew by 1.39% to $2.2 billion in 2024, then fell by 8.9% to $2.0 billion in 2025.
  • Its Invested Capital stands at $2.0 billion for Q3 2025, versus $2.0 billion for Q2 2025 and $1.8 billion for Q1 2025.